The significance of a novel inflammatory biomarker, presepsin, in predicting disease prognosis in patients with COVID-19.

C Karacaer,H Sert,T Demirci,C Varım,G Kaya,A B Genc, D Cekic H Ergenc, Z Ergenc,S Yaylacı,A Nalbant,T Kaya, A Demirci, K E Oztop

European review for medical and pharmacological sciences（2022）

引用 0|浏览14

暂无评分

摘要

Serum presepsin levels were found to be significantly higher in moderate clinical group COVID-19 patients compared to mild group. Presepsin, a new inflammatory biomarker, may be useful in predicting the prognosis and early treatment of COVID-19 infection.

查看译文

关键词

COVID-19 disease,C-Reactive Protein to Albumin Ratio,Presepsin,Prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要